Inventor · disambiguated record
Frank Stappenbeck
Also filed as: STAPPENBECK FRANK
19 granted patents·8 pending applications·220 citations·filing 2001–2021
94Inventor score
Top patents by PatentIndex Score
27 records- 0194US7427628B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2006·Granted Sep 23, 2008·23 cites·14 claims
- 0293US7008949B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsWYETH CORP·Filed 2003·Granted Mar 7, 2006·45 cites·16 claims
- 0393US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 0492US7026328B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsWYETH CORP·Filed 2003·Granted Apr 11, 2006·48 cites·18 claims
- 0590US7135477B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Nov 14, 2006·28 cites·9 claims
- 0687US7205310B2Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted Apr 17, 2007·11 cites·19 claims
- 0786US7335663B2Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Feb 26, 2008·19 cites·8 claims
- 0885US8030328B2Imidazolone phenylalanine derivativesELAN PHARM INC·Filed 2006·Granted Oct 4, 2011·10 cites·27 claims
- 0984US9637514B1Oxysterols and hedgehog signalingMAX BIOPHARMA INC·Filed 2016·Granted May 2, 2017·2 cites·20 claims
- 1079US9717742B2Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesisUNIV CALIFORNIA·Filed 2013·Granted Aug 1, 2017·4 cites·11 claims
- 1165US2008182850A13-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4ELAN PHARM INC·Filed 2007·Application pending·0 cites
- 1261US10869875B2Oxysterols and Hedgehog signalingMAX BIOPHARMA INC·Filed 2016·Granted Dec 22, 2020·0 cites·19 claims
- 1359US7763632B2Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jul 27, 2010·0 cites·23 claims
- 1457US8158642B2Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4SEMKO CHRISTOPHER MICHAEL·Filed 2009·Granted Apr 17, 2012·0 cites·22 claims
- 1557US2017189420A1Oxysterols and hedgehog signalingMAX BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 1656US7727996B2Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·0 cites·32 claims
- 1756US7511052B2Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2006·Granted Mar 31, 2009·0 cites·30 claims
- 1855US7365073B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2004·Granted Apr 29, 2008·0 cites·10 claims
- 1953US2023381201A1Methods and compositions for treating fibrotic diseasesMAX BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2050US2023234982A1Oxysterol compounds and uses thereofMAX BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2147US8367688B2Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2010·Granted Feb 5, 2013·0 cites·22 claims
- 2245US2005239804A1Method for improved chemical synthesis of guanidinium alkaloidsUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 2345US2023364111A1Methods and compositions for treating viral infectionsMAX BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2443US9683009B2Bone-selective osteogenic oxysterol-bone targeting agentsUNIV CALIFORNIA·Filed 2014·Granted Jun 20, 2017·0 cites·12 claims
- 2543US2015140059A1Novel oxysterol analogue, oxy149, induces osteogenesis and hedgehog signaling and inhibits adipogenesisUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 2637US2003176697A1Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agentsUNIV CALIFORNIA·Filed 2002·Application pending·0 cites
- 2735US10421773B2Bone-selective osteogenic oxysterol bisphosphonate analogsUNIV CALIFORNIA·Filed 2015·Granted Sep 24, 2019·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Frank Stappenbeck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →